TARGETING WHAT MATTERS MOST

DEAD

Serial Number

88469695

Owner

THERAVANCE BIOPHARMA R&D IP, LLC

Attorney

Beth H. Alter

Filing Date

Jun 12, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

TARGETING WHAT MATTERS MOST Trademark

Serial Number: 88469695

TARGETING WHAT MATTERS MOST is a trademark filed by THERAVANCE BIOPHARMA R&D IP, LLC on June 12, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

THERAVANCE BIOPHARMA R&D IP, LLC (14 trademarks)

901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CA 94080

Entity Type: 16

Legal Representation

Attorney of Record

Beth H. Alter

878 trademarks filed View all →

Correspondence Address

Beth H. Alter SEWARD & KISSEL LLP

ONE BATTERY PARK PLAZA

NEW YORK

NY 10004

UNITED STATES

Trademark Details

Filing Date

June 12, 2019

Registration Date

Not Registered

Filing History

ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT

Jan 12, 2021 MAB1

ABANDONMENT - EXPRESS MAILED

Jan 12, 2021 ABN1

TEAS EXPRESS ABANDONMENT RECEIVED

Jan 11, 2021 EXAR

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jan 8, 2021 CHAN

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 8, 2021 TCCA

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jan 8, 2021 COAR

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Aug 24, 2020 RCSC

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Feb 17, 2020 GNS3

LETTER OF SUSPENSION E-MAILED

Feb 17, 2020 GNSL

SUSPENSION LETTER WRITTEN

Feb 17, 2020 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 23, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 22, 2020 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 22, 2020 TROA

NON-FINAL ACTION MAILED

Jul 22, 2019 CNRT

NON-FINAL ACTION WRITTEN

Jul 10, 2019 CNRT

ASSIGNED TO EXAMINER

Jul 8, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 25, 2019 NWOS

NEW APPLICATION ENTERED

Jun 15, 2019 NWAP

Related Trademarks

More from this Owner

TRANSFORMATIONAL MEDICINES THAT MAKE A DIFFERENCE

MEDICINES THAT MAKE A TRANSFORMATIONAL DIFFERENCE

TRANSFORMATIONAL MEDICINES THAT MAKE A DIFFERENCE

Serial #86248968

More in Same Class

CHOLEXMAX